alloxan has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 20 studies
Alloxan: Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.
alloxan : A member of the class of pyrimidones, the structure of which is that of perhydropyrimidine substituted at C-2, -4, -5 and -6 by oxo groups.
Excerpt | Relevance | Reference |
---|---|---|
" We investigated whether increases in the duration of hyperglycemia result in the development of corneal lesions in a mouse model of alloxan (AL)- or streptozotocin (STZ)-induced type 1 diabetes." | 7.88 | Extended Duration of Hyperglycemia Result in Human-Like Corneal Nerve Lesions in Mice With Alloxan- and Streptozotocin-Induced Type 1 Diabetes. ( Matsuura, T; Ozaki, K; Terayama, Y, 2018) |
" We investigated whether increases in the duration of hyperglycemia result in the development of corneal lesions in a mouse model of alloxan (AL)- or streptozotocin (STZ)-induced type 1 diabetes." | 3.88 | Extended Duration of Hyperglycemia Result in Human-Like Corneal Nerve Lesions in Mice With Alloxan- and Streptozotocin-Induced Type 1 Diabetes. ( Matsuura, T; Ozaki, K; Terayama, Y, 2018) |
"The efficacy of Momordica charantia (MC), Eugenia jambolana (EJ), Tinospora cordifolia (TC) and Mucuna pruriens (MP) was assessed in the prevention of murine alloxan dibetic cataract." | 3.71 | Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts. ( Biswas, NR; Grover, JK; Rathi, SS; Vikrant, V, 2002) |
"Lycopene (4 mg/kg) was administered to the rats in LG once a day for 3 months." | 1.51 | The effects of lycopene on alloxan induced diabetic optic neuropathy. ( Elpeze, B; Icel, A; Icel, E; Karakurt, Y; Keskin Çimen, F; Süleyman, H; Uçak, T, 2019) |
"Alloxan treatment caused hyperglycemia and reduced boy growth." | 1.29 | Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P. ( Di Giulio, AM; Gorio, A; Lesma, E, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (35.00) | 18.7374 |
1990's | 3 (15.00) | 18.2507 |
2000's | 2 (10.00) | 29.6817 |
2010's | 6 (30.00) | 24.3611 |
2020's | 2 (10.00) | 2.80 |
Authors | Studies |
---|---|
El-Sherbeeny, NA | 1 |
Ibrahiem, AT | 1 |
Ali, HS | 1 |
Farag, NE | 1 |
Toraih, EA | 1 |
Zaitone, SA | 1 |
Icel, E | 1 |
Icel, A | 1 |
Uçak, T | 1 |
Karakurt, Y | 1 |
Elpeze, B | 1 |
Keskin Çimen, F | 1 |
Süleyman, H | 1 |
Ozaki, K | 1 |
Terayama, Y | 1 |
Matsuura, T | 1 |
Kara, A | 1 |
Unal, D | 1 |
Simsek, N | 1 |
Yucel, A | 1 |
Yucel, N | 1 |
Selli, J | 1 |
Raafat, K | 1 |
Aboul-Ela, M | 1 |
El-Lakany, A | 1 |
Volchegorskiĭ, IA | 1 |
Rassokhina, LM | 1 |
Miroshnichenko, IIu | 1 |
Thorve, VS | 1 |
Kshirsagar, AD | 1 |
Vyawahare, NS | 1 |
Thakurdesai, PA | 1 |
Bhandare, AM | 1 |
Spadella, CT | 1 |
Lucchesi, AN | 1 |
Alberti, S | 1 |
Resende, LA | 1 |
Rathi, SS | 1 |
Grover, JK | 1 |
Vikrant, V | 1 |
Biswas, NR | 1 |
Jianbo, L | 1 |
Chengya, W | 1 |
Jiawei, C | 1 |
Xiaolu, L | 1 |
Zhenqing, F | 1 |
Hongtai, M | 1 |
Brown, MR | 1 |
Dyck, PJ | 1 |
McClearn, GE | 1 |
Sima, AA | 1 |
Powell, HC | 1 |
Porte, D | 1 |
Moore, SA | 1 |
Peterson, RG | 1 |
Felten, DL | 1 |
O'Connor, BL | 1 |
Di Giulio, AM | 2 |
Lesma, E | 1 |
Gorio, A | 3 |
Yildiz, O | 1 |
Ozata, M | 1 |
Ozkardeş, A | 1 |
Deniz, G | 1 |
Yildirimkaya, M | 1 |
Corakçi, A | 1 |
Yardim, M | 1 |
Gündoğan, MA | 1 |
Paro, M | 1 |
Italiano, G | 1 |
Travagli, RA | 1 |
Petrelli, L | 1 |
Zanoni, R | 1 |
Prosdocimi, M | 1 |
Fiori, MG | 2 |
Marini, P | 2 |
Vitadello, M | 1 |
Bianchi, R | 1 |
Triban, C | 2 |
Tenconi, B | 1 |
La Croix, R | 1 |
Mantegazza, P | 1 |
Cattabeni, F | 1 |
Guidolin, D | 1 |
Fabris, M | 1 |
Schiavinato, A | 1 |
Donà, M | 1 |
Bortolami, MC | 1 |
Di Giamberardino, L | 1 |
Goto, I | 1 |
Peters, HA | 1 |
Shorr, SS | 1 |
Bloom, FE | 1 |
20 other studies available for alloxan and Asymmetric Diabetic Proximal Motor Neuropathy
Article | Year |
---|---|
Carbamazepine conquers spinal GAP43 deficiency and sciatic Nav1.5 upregulation in diabetic mice: novel mechanisms in alleviating allodynia and hyperalgesia.
Topics: Alloxan; Animals; Carbamazepine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Mod | 2020 |
The effects of lycopene on alloxan induced diabetic optic neuropathy.
Topics: Alloxan; Animals; Anti-Inflammatory Agents; Antioxidants; Diabetes Mellitus, Experimental; Diabetic | 2019 |
Extended Duration of Hyperglycemia Result in Human-Like Corneal Nerve Lesions in Mice With Alloxan- and Streptozotocin-Induced Type 1 Diabetes.
Topics: Alloxan; Animals; Cornea; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuro | 2018 |
Ultra-structural changes and apoptotic activity in cerebellum of post-menopausal-diabetic rats: a histochemical and ultra-structural study.
Topics: Aging; Alloxan; Animals; Apoptosis; Apoptosis Regulatory Proteins; Brain Edema; Cerebellum; Diabetes | 2014 |
Alloxan-induced diabetic thermal hyperalgesia, prophylaxis and phytotherapeutic effects of Rheum ribes L. in mouse model.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathie | 2021 |
[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
Topics: Alloxan; Animals; Conditioning, Classical; Diabetes Mellitus, Experimental; Diabetic Neuropathies; D | 2011 |
H. Spinosa T. Anders ameliorates diabetic neuropathy in Wistar albino rats.
Topics: Acanthaceae; Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Administ | 2012 |
Early pancreas transplant improves motor nerve conduction in alloxan-induced diabetic rats.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Progression; Glyca | 2012 |
Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts.
Topics: Administration, Oral; Alloxan; Animals; Blood Glucose; Cataract; Diabetes Mellitus, Experimental; Di | 2002 |
The role of IGF-1 gene expression abnormality in pathogenesis of diabetic peripheral neuropathy.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Electrophysiology; Evoked | 2002 |
Central and peripheral nervous system complications.
Topics: Alloxan; Animals; Central Nervous System Diseases; Cricetinae; Cricetulus; Diabetic Neuropathies; Di | 1982 |
A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Motor Neurons; Neura | 1980 |
Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P.
Topics: Alloxan; Animals; Axons; Blood Glucose; Body Weight; Carnitine; Diabetic Neuropathies; Male; Rats; R | 1995 |
Comparison of the effects of aminoguanidine and L-carnitine treatments on somatosensorial evoked potentials in alloxan-diabetic rats.
Topics: Alloxan; Animals; Blood Glucose; Body Weight; Carnitine; Diabetes Mellitus, Experimental; Diabetic N | 1996 |
Cystometric changes in alloxan diabetic rats: evidence for functional and structural correlates of diabetic autonomic neuropathy.
Topics: Alloxan; Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuro | 1990 |
Impaired axonal transport of acetylcholinesterase in the sciatic nerve of alloxan-diabetic rats: effect of ganglioside treatment.
Topics: Acetylcholinesterase; Alloxan; Animals; Axonal Transport; Diabetes Mellitus, Experimental; Diabetic | 1986 |
Denervation and hyperinnervation in the nervous system of diabetic animals. I. The autonomic neuronal dystrophy of the gut.
Topics: Alloxan; Animals; Autonomic Nervous System; Biogenic Monoamines; Diabetes Mellitus, Experimental; Di | 1989 |
Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy.
Topics: Alloxan; Animals; Antibodies, Monoclonal; Axons; Blood Glucose; Body Weight; Diabetes Mellitus, Expe | 1989 |
Serial in vivo determination of motor conduction velocity in tails of allaxanized non-diabetic and diabetic rats.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; El | 1974 |
Fine structure of islet-cell innervation in the pancreas of normal and alloxan-treated rats.
Topics: Alloxan; Animals; Axons; Diabetic Neuropathies; Ganglia, Autonomic; Indicators and Reagents; Iodides | 1970 |